Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
Taisho Pharmaceutical Holdings Co Ltd
Tax Provision
Taisho Pharmaceutical Holdings Co Ltd
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
|
Tax Provision
-¥6.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
18%
|
CAGR 10-Years
10%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Tax Provision
¥30.1B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Tax Provision
-¥12.7B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
7%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Tax Provision
-¥21.8B
|
CAGR 3-Years
17%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Tax Provision
-¥118.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-17%
|
|
Astellas Pharma Inc
TSE:4503
|
Tax Provision
-¥35.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-2%
|
See Also
What is Taisho Pharmaceutical Holdings Co Ltd's Tax Provision?
Tax Provision
-6.2B
JPY
Based on the financial report for Dec 31, 2023, Taisho Pharmaceutical Holdings Co Ltd's Tax Provision amounts to -6.2B JPY.
What is Taisho Pharmaceutical Holdings Co Ltd's Tax Provision growth rate?
Tax Provision CAGR 10Y
10%
Over the last year, the Tax Provision growth was 28%. The average annual Tax Provision growth rates for Taisho Pharmaceutical Holdings Co Ltd have been 13% over the past three years , 18% over the past five years , and 10% over the past ten years .